• $3 billion investment globally, in manufacturing and engineering footprint, R&D and partnerships • Workforce expansion with more than 8,000 people hired • 150 GW of HVDC links integrated into the power system by Hitachi Energy Zurich, Switzerland, Oct. 24, 2023 (GLOBE NEWSWIRE) — Hitachi Energy, a global technology leader

Strategic acquisition adds advanced power electronics and energy management software capabilities to meet accelerated, global demand for battery energy storage solutions Zurich, Switzerland, Oct. 24, 2023 (GLOBE NEWSWIRE) — Hitachi Energy, a global technology leader that is advancing a sustainable energy future for all, announced today that it has acquired

UK, Oct. 23, 2023 (GLOBE NEWSWIRE) — October 23rd, London, UK Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice Dom will be responsible for leading the company’s overall creative strategy, with a specific focus on

YouthADAPT Challenge 2023 is launched by the African Development Bank, the Africa Climate Change Fund and the Global Center on Adaptation. Abidjan, Côte d’Ivoire, Oct. 23, 2023 (GLOBE NEWSWIRE) — The Africa Adaptation Acceleration Program, a joint initiative of the African Development Bank (“the Bank”) and the Global Center on

Selon un rapport de Wood Mackenzie, de nouveaux complexes métalliques verront le jour à mesure que l’industrie sidérurgique accélérera ses efforts de réduction des émissions de carbone LONDRES, HOUSTON et SINGAPOUR, 19 oct. 2023 (GLOBE NEWSWIRE) — Selon le dernier rapport Horizons de Wood Mackenzie, l’industrie sidérurgique devrait subir une

O relatório da Wood Mackenzie afirma que novos centros metálicos emergirão à medida que a indústria siderúrgica acelera os esforços de redução de carbono LONDRES, HOUSTON e SINGAPURA, Oct. 19, 2023 (GLOBE NEWSWIRE) — De acordo com o último relatório Horizons da Wood Mackenzie, a indústria siderúrgica deverá passar por

Clinical Trial Preparation WASHINGTON, Oct. 19, 2023 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute has launched a Phase 2 clinical trial for its vaccine candidate against the lethal Marburg virus. Healthy volunteers received the single-dose vaccine at Makerere University Walter Reed Project (MUWRP) in Kampala, Uganda today. There are currently

Clinical Trial Preparation WASHINGTON, Oct. 19, 2023 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute has launched a Phase 2 clinical trial for its vaccine candidate against the lethal Marburg virus. Healthy volunteers received the single-dose vaccine at Makerere University Walter Reed Project (MUWRP) in Kampala, Uganda today. There are currently